HOTBIO A holistic approach to training a new generation of scientists in marine biodiscovery
- Coordinator
- Universitetet I Tromsoe - Norges Arktiske Universitet, Norway
- Runs
- 1 January 2023 to 30 June 2027
- Status
- Running
- EU funding
- €2.4m
- Total cost
- —
- Partners
- 20 organisations in 11 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101072475
What the project is doing
In the project's own words, from its summary on CORDIS.
The HOTBIO consortium will train a new generation of early-stage scientists to take marine microbial natural products from the seabed to the bedside. They will be involved in every stage of the pipeline from microbial isolation through compound purification and identification to making analogues with desirable drug-like properties. They will gain associated skills in access and benefit sharing, intellectual property and entrepreneurship.
Students graduating from HOTBIO will be in a unique position to enter a challenging labour market as they will have received multidisciplinary training at world leading research groups in academia as well as at industry partners. Mentorship will be provided by industrial scientists and recent graduates from the MSCA ITN MarPipe. The HOTBIO consortium consists of eight beneficiaries from seven European countries, including two members from non-academic sectors, that will host ten PhD students.
Three more PhD students hosted by two Swiss associated partners will be funded by the Swiss State Secretariat for Education, Research and Innovation. In addition to secondments at the partners in Europe, students will also get the opportunity to do secondments in low-to-middle income countries (LMICs) in Africa and Asia to get a deeper understanding of how modern research can be done in resource-limited setting. HOTBIO expands a conventional marine biodiscovery pipeline by including computer aided drug design (CADD), chemical synthesis of optimized compounds (i.e. medicinal chemistry), target deconvolution and extensive ADMET profiling.
This will advance the bioactive microbial secondary metabolites to the later stages of preclinical development, and it will also inform the decisions and priorities of what kind of compounds that should be targeted in the initial phase of the drug discovery process. The downstream development will include hit compounds from earlier projects.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitetet I Tromsoe - Norges Arktiske Universitet | Tromso | Norway | Coordinator |
| Oxford Antibiotic Group GmbH | Tulln | Austria | Associatedpartner |
| Abs-International | Gent | Belgium | Participant |
| Katholieke Universiteit Leuven | Leuven | Belgium | Associatedpartner |
| Universitat Zurich | Zurich | Switzerland | Associatedpartner |
| Universite De Lausanne | Lausanne | Switzerland | Associatedpartner |
| Christian-Albrechts-Universitaet Zu Kiel | Kiel | Germany | Associatedpartner |
| Helmholtz-Zentrum Fur Ozeanforschung Kiel (geomar) | Kiel | Germany | Participant |
| Lead Discovery Center GmbH | Dortmund | Germany | Participant |
| Ruhr-Universitaet Bochum | Bochum | Germany | Associatedpartner |
| Fundacion Centro De Excelencia En Investigacion De Medicamentos Innovadores En Andalucia | Armilla Granada | Spain | Participant |
| Universidad De Granada | Granada | Spain | Associatedpartner |
| University of Ghana | Accra | Ghana | Associatedpartner |
| Sathyabama Institute of Science and Technology | Chennai | India | Associatedpartner |
| Stazione Zoologica Anton Dohrn | Napoli | Italy | Participant |
| Universita Degli Studi Di Messina | Messina | Italy | Associatedpartner |
| Bacto - Tech sp. z o.o. | Toruń | Poland | Associatedpartner |
| Uniwersytet Mikolaja Kopernika | Torun | Poland | Participant |
| The Open University | Milton Keynes | United Kingdom | Associatedpartner |
| The University Court of the University of Aberdeen | Aberdeen | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI